SCHEMBL7522965

SCHEMBL7522965

NC(=O)NC(=O)NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL653996 0.82 CRBN (0.53) —
SCHEMBL27905681 0.79 CRBN (0.50) —
SCHEMBL29509273 0.79 CRBN (0.50) —
SCHEMBL29509217 0.79 CRBN (0.50) —
SCHEMBL27715006 0.79 TSHR (0.53) —
SCHEMBL28291541 0.78 — —
Carbamic Acid SCHEMBL27715066 0.76 ACHE (0.50) —
SCHEMBL10373460 0.75 — —
Hydroxyurea SCHEMBL4004 0.73 — —
SCHEMBL15045 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906271-B1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AG (DE) 2002-02-06 — — EP claimed
EP-0906271-A1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AKTIENGESELLSCHAFT (DE) 1999-04-07 — — EP claimed
WO-1997046518-A1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AKTIENGESELLSCHAFT (DE) 1997-12-11 — — WO claimed
JP-55080522-A — — None — — JP disclosed
JP-52042919-A — — None — — JP disclosed
CN-111655257-B ASH1L inhibitors and methods of treatment therewith 密歇根大学董事会 2024-11-05 — — CN disclosed
CN-117562992-A Anti-human VISTA antibodies and uses thereof 伊穆奈克斯特股份有限公司 2024-02-20 — — CN disclosed
CN-116848091-A Inhibitors of ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP 1) and uses thereof 1CBIO公司 2023-10-03 — — CN disclosed
CN-109789201-B Anti-human VISTA antibodies and uses thereof 伊穆奈克斯特股份有限公司 2023-06-16 — — CN disclosed
CN-115397974-A Stromal-free T cell differentiation from human pluripotent stem cells 儿童医疗中心有限公司 2022-11-25 — — CN disclosed
CN-111655257-A ASH1L inhibitors and methods of treatment therewith 密歇根大学董事会 2020-09-11 — — CN disclosed
CN-102241791-A Method for modifying agarose gel with N-hydroxyl imidodicarbonic diamide UNIV JIANGNAN 2011-11-16 — — CN disclosed
EP-0906271-B1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AG (DE) 2002-02-06 — — EP disclosed
EP-0906271-B1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AG (DE) 2002-02-06 — — EP disclosed
EP-0906271-A1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AKTIENGESELLSCHAFT (DE) 1999-04-07 — — EP disclosed
EP-0906271-A1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AKTIENGESELLSCHAFT (DE) 1999-04-07 — — EP disclosed
WO-1997046518-A1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AKTIENGESELLSCHAFT (DE) 1997-12-11 — — WO disclosed
WO-1997046518-A1 CARBAMOYL CARBOXYLIC ACID AMIDE OXIMES BASF AKTIENGESELLSCHAFT (DE) 1997-12-11 — — WO disclosed
JP-S5580522-A ACRYLIC FIBER ASAHI CHEM IND CO LTD 1980-06-17 — — JP disclosed
JP-S5242919-A ACRYLIC FIBERS ASAHI CHEM IND CO LTD 1977-04-04 — — JP disclosed
Send feedback